Abstract
Factor XIII (FXIII) is a unique clotting factor activated in the last stage of the coagulation cascade, with multiple other plasmatic and cellular functions, outside of the traditional homeostasis. Literature data show that FXIII is expressed in skin lesions in the course of various inflammatory skin disorders. Dermis contains a series of macrophages and dendritic cells, which express different phenotypes including FXIII. Increased levels of FXIII-positive cells are present in specific cutaneous inflammatory and fibrotic conditions. The aim of this review is to provide the relationship between FXIII and the development of the inflammatory skin lesions.
Similar content being viewed by others
References
Muszbek L, Bereczky Z, Bagoly Z, Komaromi I, Katona E: Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011;91:931–972.
Adany R, Bardos H: Factor XIII subunit A as an intracellular transglutaminase. Cell Mol Life Sci 2003;60:1049–1060.
Nakano Y, Al-Jallad HF, Mousa A, Kaartinen MT: Expression and localization of plasma transglutaminase factor XIIIA in bone. J Histochem Cytochem 2007;55:675–685.
Cerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT: Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989;121:421–431.
Akagi A, Tajima S, Ishibashi A, Matsubara Y, Takehana M, Kobayashi S, Yamaguchi N: Type XVI collagen is expressed in factor XIIIa+ monocytederived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. J Invest Dermatol 2002;118:267–274.
Bagoly Z, Katona E, Muszbek L: Factor XIII and inflammatory cells. Thromb Res 2012;129Suppl 2:S77–S81.
Henriksson P, Becker S, Lynch G, McDonagh J: Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985;76:528–534.
Jayo A, Conde I, Lastres P, Jimenez-Yuste V, Gonzalez-Manchon C: Possible role for cellular FXIII in monocyte-derived dendritic cell motility. Eur J Cell Biol 2009;88:423–431.
Quatresooz P, Paquet P, Hermanns-Le T, Pierard GE: Molecular mapping of Factor XIIIa-enriched dendrocytes in the skin (Review). Int J Mol Med 2008;22:403–409.
Regezi JA, Daniels TE, Saeb F, Nickoloff BJ: Increased submucosal factor XIIIa-positive dendrocytes in oral lichen planus. J Oral Pathol Med 1994;23:114–118.
Schaumburg-Lever G, Gehring B, Kaiserling E: Ultrastructural localization of factor XIIIa. J Cutan Pathol 1994;21:129–134.
Torocsik D, Bardos H, Hatalyak Z, Dezso B, Losonczy G, Paragh L, Peter Z, Balazs M, Remenyik E, Adany R: Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica. J Eur Acad Dermatol Venereol 2013.
Altman DA, Nickoloff BJ, Fivenson DP: Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 1993;20:154–158.
Cerio R, Spaull J, Oliver GF, Jones WE: A study of factor XIIIa and MAC 387 immunolabeling in normal and pathological skin. Am J Dermatopathol 1990;12:221–233.
Criado PR, Jardim Criado RF, Sotto MN, Pagliari C, Takakura CH, Vasconcellos C: Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria. J Eur Acad Dermatol Venereol 2013;27:e105–e112.
Denton KJ, Cotton DW, Wright A, Hird P: Factor XIIIa in nodular malignant melanoma and Spitz naevi. Br J Dermatol 1990;123:783–786.
Hermanns-Le T, Paquet P, Pierard-Franchimont C, Arrese JE, Pierard GE: Regulatory function of factor-XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. A hypothesis. Dermatology 1999;198:184–186.
Nickoloff BJ, Griffiths CE: Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi’s sarcomas. Science 1989;243:1736–1737.
Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA: Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 2007;117:2517–2525.
Bagoly Z, Fazakas F, Komaromi I, Haramura G, Toth E, Muszbek L: Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit. Thromb Haemost 2008;99:668–674.
Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A: Effect of FXIII on monocyte and fibroblast function. Cell Physiol Biochem 2007;19:113–120.
Cordell PA, Kile BT, Standeven KF, Josefsson EC, Pease RJ, Grant PJ: Association of coagulation factor XIII-A with Golgi proteins within monocytemacrophages: implications for subcellular trafficking and secretion. Blood 2010;115:2674–2681.
Hoppe B, Haupl T, Skapenko A, Ziemer S, Tauber R, Salama A, Schulze-Koops H, Burmester GR, Dorner T: Fibrinogen and factor XIII A-subunit genotypes interactively influence C-reactive protein levels during inflammation. Ann Rheum Dis 2012;71:1163–1169.
Semba U, Chen J, Ota Y, Jia N, Arima H, Nishiura H, Yamamoto T: A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIacatalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation. Am J Pathol 2010;176:1542–1551.
Torocsik D, Szeles L, Paragh G, Jr., Rakosy Z, Bardos H, Nagy L, Balazs M, Inbal A, Adany R: Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages. Thromb Haemost 2010;104:709–717.
Navarrete M, Garcia J, Dutzan N, Henriquez L, Puente J, Carvajal P, Hernandez M, Gamonal J: IFN-gamma, IL-6, IL-4, and FXIII-A as Indirect Markers of the Classical and Alternative Macrophage Activation Pathways in Chronic Periodontitis. J Periodontol 2013.
Jorundsson E, Press CM, Landsverk T: Factor XIIIa positive dendritic cells are a major accessory cell population in the elicitation phase of DNCBinduced contact hypersensitivity. Vet Immunol Immunopathol 1999;71:99–113.
Talme T, Schultzberg M, Sundqvist KG, Marcusson JA: Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment. Acta Derm Venereol 1999;79:44–48.
Okamoto M, Yamamoto T, Matsubara S, Kukita I, Takeya M, Miyauchi Y, Kambara T: Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. Biochim Biophys Acta 1992;1138:53–61.
Torocsik D, Bardos H, Nagy L, Adany R: Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 2005;62:2132–2139.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Włodarczyk, M., Sobolewska, A., Lesiak, A. et al. The role of factor XIII-A in the development of inflammatory skin lesions. cent.eur.j.biol. 9, 869–873 (2014). https://doi.org/10.2478/s11535-014-0319-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-014-0319-9